CD8+ T lymphocytes are recruited to neoplastic cervix
- PMID: 7559915
- DOI: 10.1007/BF01543104
CD8+ T lymphocytes are recruited to neoplastic cervix
Abstract
ToliicIV distinguish normal cervical lymphocyte populations from phenotypes recruited to the cervix in response to cervical neoplasia, lymphocytes were isolated from normal and neoplastic cervix. A portion of the cervical transformation zone was obtained from 19 patients with pathologically confirmed cervical intraepithelial neoplasia and from 20 patients with normal cervices undergoing hysterectomy for benign indications. Mononuclear cells were harvested from cervical tissue using a serial, multienzymatic digestion procedure and enriched by density gradient centrifugation. Isolated cell populations were stained with surface marker-specific monoclonal antibodies and analyzed by fluorescent activated cell sorter to determine the percentage of B cells, total T cells, CD4+ T cells, CD8+ T cells, and natural killer (NK) cells. The distribution of circulating peripheral blood lymphocyte phenotypes was similar for both patients with neoplasia and normal controls. A marked disparity in the proportions of NK cells and T cells was demonstrated among lymphocyte phenotypes infiltrating the cervix. The percentage of CD4+ T cells and NK cells was significantly depressed (P = 0.04, P = 0.03, respectively) in dysplastic tissue as compared to normal cervical tissue. In contrast, the proportion of CD8+ T cells was significantly increased in the dysplastic tissue (P = 0.0001). Analysis of immunocompetent cells in the circulation appears to have little correlation with immunocytes present in the dysplastic epithelium. The depression in the proportion of CD4+ T lymphocytes and NK cells at the cervical squamocolumnar junction reflects a local recruitment of CD8+ T cells to the site of neoplasia in the cervix.
Similar articles
-
A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix.Cell Mol Immunol. 2011 Jan;8(1):59-66. doi: 10.1038/cmi.2010.56. Epub 2010 Nov 22. Cell Mol Immunol. 2011. PMID: 21200385 Free PMC article.
-
B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.Hum Immunol. 2014 Dec;75(12):1203-9. doi: 10.1016/j.humimm.2014.10.002. Epub 2014 Oct 13. Hum Immunol. 2014. PMID: 25446402
-
Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.Gynecol Oncol. 2001 Jun;81(3):424-32. doi: 10.1006/gyno.2001.6200. Gynecol Oncol. 2001. PMID: 11371133
-
Inflammatory Stroma of Lymphoepithelioma-like Carcinoma of the Cervix: Immunohistochemical Study of 3 Cases and Review of the Literature.Int J Gynecol Pathol. 2018 Sep;37(5):482-487. doi: 10.1097/PGP.0000000000000446. Int J Gynecol Pathol. 2018. PMID: 28985196 Review.
-
[Intraepithelial neoplasia of the cervix].Ginecol Obstet Mex. 1984 Dec;52(332):285-303. Ginecol Obstet Mex. 1984. PMID: 6397410 Review. Spanish. No abstract available.
Cited by
-
The Effects of Preoperative Oral Carbohydrate on Frequency of T and NK Cells in Patients with Cervical Cancer Treated Using Neoadjuvant Chemotherapy and Surgery: A Prospective Cohort Study.Biomed Res Int. 2020 Mar 16;2020:2101480. doi: 10.1155/2020/2101480. eCollection 2020. Biomed Res Int. 2020. PMID: 32309426 Free PMC article.
-
Location and Density of Immune Cells in Precursor Lesions and Cervical Cancer.Cancer Microenviron. 2013 Apr;6(1):69-77. doi: 10.1007/s12307-012-0097-8. Epub 2012 Jan 31. Cancer Microenviron. 2013. PMID: 22290207 Free PMC article.
-
Spontaneous regression of a residual pineal tumor after resection of a cerebellar vermian germinoma.J Neurooncol. 1999 Jan;41(1):65-70. doi: 10.1023/a:1006155120191. J Neurooncol. 1999. PMID: 10222424
-
Tumor Immune Microenvironment in Gynecologic Cancers.Cancers (Basel). 2023 Jul 28;15(15):3849. doi: 10.3390/cancers15153849. Cancers (Basel). 2023. PMID: 37568665 Free PMC article. Review.
-
Expression of the SART-1 antigens in uterine cancers.Jpn J Cancer Res. 1998 Dec;89(12):1292-5. doi: 10.1111/j.1349-7006.1998.tb00526.x. Jpn J Cancer Res. 1998. PMID: 10081490 Free PMC article.